Rice Hall James & Associates »

Revance Therapeutics shares owned by Rice Hall James & Associates

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Rice Hall James & Associates from 13F filings

Historical chart of Rice Hall James & Associates investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Rice Hall James & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Rice Hall James & Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.7M 746k 4.92
2023-12-31 $6.7M 758k 8.79
2023-09-30 $7.8M 684k 11.47
2023-06-30 $14M 553k 25.31
2023-03-31 $26M 809k 32.21
2022-12-31 $16M 876k 18.46
2022-09-30 $24M 897k 27.00
2022-06-30 $15M 1.1M 13.82
2022-03-31 $22M 1.1M 19.50
2021-12-31 $18M 1.1M 16.32
2021-09-30 $26M 920k 27.86
2021-06-30 $27M 926k 29.64
2021-03-31 $31M 1.1M 27.95
2020-12-31 $32M 1.1M 28.34
2020-09-30 $28M 1.1M 25.14
2020-06-30 $25M 1.0M 24.42
2020-03-31 $15M 1.0M 14.80
2019-12-31 $17M 1.1M 16.23
2019-09-30 $14M 1.1M 13.00
2019-06-30 $11M 883k 12.97
2019-03-31 $1.8M 117k 15.76
2018-12-31 $668k 33k 20.12
2018-09-30 $606k 24k 24.86